Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 258-061-6 | CAS number: 52636-67-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD 487 (Draft version)
- Deviations:
- yes
- Remarks:
- human peripheral blood lymphocytes
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- The Study was conducted in compliance with Principles of Good Laboratory Practice, Paris 1998, in compliance with the DIRECTIVE 2004/9/EC, the DIRECTIVE 2004/10/EC and with the Slovak Government Act № 67/2010 Coll. and the Slovak Government Decree № 320
- Type of assay:
- in vitro mammalian cell micronucleus test
Test material
- Reference substance name:
- Sulphamidic acid
- EC Number:
- 226-218-8
- EC Name:
- Sulphamidic acid
- Cas Number:
- 5329-14-6
- Molecular formula:
- H3NO3S
- IUPAC Name:
- sulfamic acid
- Test material form:
- other:
Constituent 1
Method
- Target gene:
- Micronuclei
Species / strain
- Species / strain / cell type:
- lymphocytes: human peripheral blood lymphocytes
- Details on mammalian cell type (if applicable):
- Donors: Blood from two different healthy, non-smoking, young (between 31- 34 years of age) people
(always man and women)
Number: For each test replicate two new donors were available.
Source: Department of Haematology and Transfusiology, Šmidke’s street, Bratislava, SLOVAKIA
Treatment: Whole blood treated with an anti-coagulant (heparin), were added to culture medium
containing a mitogen (e.g. phytohemagglutinin) (PHA) and incubated at 37°C. - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 MIX
- Test concentrations with justification for top dose:
- 860, 86, 8.6, 0.86, 0.086, 0.0086, 0.00086, 0 µg / mL of blood cultivated
- Vehicle / solvent:
- Ultrapure water
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Thiotepa (CAS: 52-24-4)
- Remarks:
- -S9 mix (without metabolic activation); concentration: 2 µg.ml -1
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- +S9 mix (with metabolic activation); concentration: 80 µg.ml -1
- Details on test system and experimental conditions:
- TEST SYSTEM:
Cell used: human peripheral blood lymphocytes
Donors: Blood from two different healthy, non-smoking, young (between 31- 34 years of age) people (always man and women)
Number: For each test replicate two new donors were available.
Source: Department of Haematology and Transfusiology, Šmidke’s street, Bratislava, SLOVAKIA
Treatment: Whole blood treated with an anti-coagulant (heparin), were added to culture medium containing a mitogen (e.g. phytohemagglutinin) (PHA) and incubated at 37°C.
TEST CONDITIONS:
Cytokinesis blocking substance: cytochalasin B
Its concentration and duration of cell exposure: 6,0 µg/mL (30 µg/5 mL), started from 44 hour of each cultivation during remaining 28 hours.
Solvent/vehicle: Ultrapure water without any side effects. Very good solubility of the substance in the water.
Composition of media: RPMI 1640, BOFES, PHAG
CO2 concentration: The concentration of CO2 = 5% in air volume in the culture incubator INCO 2 with
adjustable automatic control.
Volume of vehicle and test substance added: 200 µL (water + substance).
Incubation temperature: 37 °C
Humidity: 90% provided by 500 mL of sterile ultrapure water.
Incubation time: 72 hours (for each test replicate).
Cell density at seeding: The density of lymphocytes in the blood is given approximately at 100000 /mL. After centrifugation about 10 000 cells was spread on slides and then are fixed and count
Type and composition of metabolic activation system: liver enzyme extract from the liver of male white rats, Sprague-Dawley strain after induction of liver enzymes of animals with polychlorinated biphenyl "Delor 103”.
Composition of the activation mixture S9MIX: NADP, G-6-P, sterile distilled H2O,Na2HPO4.12H2O, KH2PO4, KCl, MgSO4, the cooling solution is added to the S9 liver extract.
Negative control: +S9MIX together with -S9MIX blood cultivated in two parallels with the addition of 200 ml ultra-pure H2O.
Positive controls: -S9 mix (without metabolic activation) + Thiotepa (CAS: 52-24-4); concentration: 2 µg/mL
+S9 mix (with metabolic activation) + Cyclophosphamide (CAS: 50-18-0): 80 µg/mL
Methods of slide preparation:
Slides are individually dipped in warm soapy solution for 2-3 hours, then each piece separately washed thoroughly with a brush and rinse with running water. Thus cleaned slides are individually dipped into sulphuric acid, at least 24 hours (or several days). In sulphuric acid glasses are again, individually, rinsed with running water and then distilled water. Cleaned slides are dipped in denatured alcohol, which are stored until use. Before use of alcohol and selected the appropriate polish cloth. Perfect degreasing and cleanliness of the slides is essential for preparing high-quality native specimens and also for colouring techniques. - Evaluation criteria:
- 1. Micronucleus diameter is greater than the third of nucleus;
2. Colour and structure of the micronucleus is consistent with the colour and structure of the nucleus;
3. Micronucleus distance from the cell nucleus is no more than 3-4 diameters nucleus
4. Micronucleus is located in the cytoplasm of binucleate cells. - Statistics:
- Student’s t - test: the arithmetic mean, standard deviation and statistical significance.
Results and discussion
Test results
- Species / strain:
- lymphocytes: human peripheral blood lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Remarks:
- Cytotoxicity in range finding test was caused by physical effect of the test substance (high pH). The highest test concentration 8600 µg / ml of blood cultivated was excluded immediately, because total coagulation of blood had occurred.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- Data on pH and osmolality of the treatment medium:
Very high concentration were excluded due to extreme coagulation effect on blood. There was also an evidence (very good cell division in the experiments) that very good buffer capacity of the culture media had occurred. (Detail will be specified in the final report).
Definition of what constitutes a micronucleus:
Origination of micronuclei involves an effect of the chemical reaction with chromosomal DNA at mitosis (at division of cell nucleus). Definition of acceptable cells for analysis: Binucleate lymphocytes; micronucleus is located in the cytoplasm of binucleate cell.
Number of cells with micronuclei and number of micronuclei per cell, given separately for each treated and control culture and defining whether from binucleate or mononucleate cells, where appropriate: All micronuclei are in binucleate cells and, in rare cases, less than 1% two or more
micronuclei are located in one binucleate cell.
Dose-response relationship: Very weak, respectively, increasing of doses of the substance does not increase effect sufficiently. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Range finding test – 1st test replicate: Dilution factor = 10, final concentration of the test substance in 1 mL blood cultivated (blood + culture medium)
8 |
8600 µg / mL |
7 |
860 µg / mL |
6 |
86 µg / mL |
5 |
8.6 µg / mL |
4 |
0.86 µg / mL |
3 |
0.086 µg / mL |
2 |
0.0086 µg / mL |
1 |
0.00086 µg / mL |
Cytotoxicity in range finding test was caused by physical effect of the test substance (low pH value). The highest test concentration (8) was excluded immediately, because total coagulation of blood had occurred. The concentrations from 1 to 7 were included in the range finding test.
Range Finding test – 1st test replicate
Number of micronuclei -S9 mix: Without metabolic activation
|
Parallel 1 |
Parallel 2 |
|
|||||||
M |
W |
M |
W |
|||||||
Substance |
Conc. (µg/mL) |
Slide1 |
S.2 |
S.3 |
S.4 |
Average |
S.D. |
t-value |
P-value(%) |
SSR |
NC |
- |
4 |
1 |
2 |
5 |
3,00 |
1,83 |
- |
- |
- |
PC |
2 |
11 |
11 |
15 |
17 |
13,50 |
3,00 |
2,99 |
0,05 |
* |
TSC7 |
860 |
2 |
7 |
5 |
4 |
4,50 |
2,08 |
0,54 |
0,6 |
N |
TSC6 |
86 |
3 |
4 |
4 |
2 |
3,25 |
0,96 |
0,12 |
> |
0,6 |
TSC5 |
8,6 |
2 |
5 |
3 |
7 |
4,25 |
2,22 |
0,44 |
> |
0,6 |
TSC4 |
0,86 |
7 |
7 |
2 |
4 |
5,00 |
2,45 |
0,65 |
0,6 |
N |
TSC3 |
0,086 |
6 |
4 |
2 |
6 |
4,50 |
1,91 |
0,57 |
0,6 |
N |
TSC2 |
0,0086 |
4 |
4 |
4 |
5 |
4,25 |
0,50 |
0,66 |
0,6 |
N |
TSC1 |
0,00086 |
3 |
4 |
5 |
4 |
4,00 |
0,82 |
0,50 |
0,4 |
N |
Range Finding test – 1st test replicate
Number of mitoses (MI) -S9 mix: Without metabolic activation
|
Parallel 1 |
Parallel 2 |
|
|||||
M |
W |
M |
W |
|
||||
Substance |
Conc. (µg/mL) |
Slide 1 |
S.2 |
S.3 |
S.4 |
Average |
S.D. |
MI(%) |
NC |
- |
42 |
71 |
104 |
38 |
63,75 |
30,60 |
6,4 |
PC |
2 |
89 |
68 |
35 |
62 |
63,50 |
22,25 |
6,4 |
TSC7 |
860 |
100 |
106 |
44 |
57 |
76,75 |
30,87 |
7,7 |
TSC6 |
86 |
131 |
108 |
84 |
31 |
88,50 |
42,87 |
8,9 |
TSC5 |
8,6 |
108 |
73 |
69 |
50 |
75,00 |
24,18 |
7,5 |
TSC4 |
0,86 |
115 |
122 |
65 |
67 |
92,25 |
30,46 |
9,2 |
TSC3 |
0,086 |
117 |
59 |
30 |
37 |
60,75 |
39,48 |
6,1 |
TSC2 |
0,0086 |
82 |
56 |
33 |
39 |
52,50 |
21,95 |
5,3 |
TSC1 |
0,00086 |
108 |
121 |
51 |
16 |
74,00 |
49,19 |
7,4 |
Dilution factor for the 2nd and 3rd test replicate = 5
From the range - finding test it was concluded that the highest test concentration in both test replicates was 344 µg/mL.
3 |
344 µg/mL |
2 |
68.8 µg/mL |
1 |
3.8 µg/mL |
Number of micronuclei -S9 mix Without metabolic activation
|
|
2nd test replicate |
3rd test replicate (repeated) |
|
|
|
|
||||||
|
|
Parallel 1 |
Parallel 2 |
Parallel 1 |
Parallel 2 |
|
|
|
|
||||
|
|
M |
W |
M |
W |
M |
W |
M |
W |
|
|
|
|
Subst. |
Conc. (µg/mL) |
Slide 1 |
S.2 |
S.3 |
S.4 |
S.5 |
S.6 |
S.7 |
S.8 |
Average |
S.D. |
t-value |
P-value (%) |
NC |
- |
3 |
5 |
1 |
4 |
1 |
3 |
2 |
2 |
2,63 |
1,41 |
|
|
PC |
2 |
19 |
11 |
14 |
22 |
19 |
13 |
17 |
12 |
15,88 |
3,94 |
3,16 |
0,01 |
TSC3 |
44 |
2 |
5 |
5 |
1 |
4 |
4 |
3 |
2 |
3,25 |
1,49 |
0,31 |
>0,6 |
TSC2 |
8,6 |
6 |
5 |
4 |
1 |
4 |
5 |
2 |
5 |
4,00 |
1,69 |
0,63 |
0,6 |
TSC1 |
3,8 |
7 |
3 |
4 |
2 |
3 |
6 |
1 |
3 |
3,63 |
2,00 |
0,41 |
>0,6 |
Number of mitoses (MI) -S9 mix Without metabolic activation
|
|
2nd test replicate |
3rd test replicate (repeated) |
|
|
|
||||||
|
|
Parallel 1 |
Parallel 2 |
Parallel 1 |
Parallel 2 |
|
|
|
||||
|
|
M |
W |
M |
W |
M |
W |
M |
W |
|
|
|
Subst. |
Conc. (µg/mL) |
Slide 1 |
S.2 |
S.3 |
S.4 |
S.5 |
S.6 |
S.7 |
S.8 |
Average |
S.D. |
MI(%) |
NC |
- |
88 |
102 |
67 |
108 |
96 |
127 |
78 |
49 |
2,63 |
1,41 |
8,9 |
PC |
2 |
65 |
59 |
30 |
70 |
25 |
73 |
49 |
29 |
15,88 |
3,94 |
5,0 |
TSC3 |
344 |
31 |
61 |
51 |
69 |
94 |
79 |
68 |
59 |
3,25 |
1,49 |
7,7 |
TSC2 |
68,6 |
22 |
108 |
55 |
99 |
90 |
76 |
64 |
52 |
4,00 |
1,69 |
8,3 |
TSC1 |
13,8 |
84 |
57 |
40 |
65 |
79 |
96 |
46 |
52 |
3,63 |
2,00 |
6,5 |
Number of micronuclei +S9 mix With metabolic activation
|
|
2nd test replicate |
3rd test replicate (repeated) |
|
|
|
|
||||||
|
|
Parallel 1 |
Parallel 2 |
Parallel 1 |
Parallel 2 |
|
|
|
|
||||
|
|
M |
W |
M |
W |
M |
W |
M |
W |
|
|
|
|
Subst. |
Conc. (µg/mL) |
Slide 1 |
S.2 |
S.3 |
S.4 |
S.5 |
S.6 |
S.7 |
S.8 |
Average |
S.D. |
t-value |
P-value (%) |
NC |
- |
4 |
3 |
2 |
1 |
3 |
5 |
3 |
2 |
2,88 |
1,25 |
|
|
PC |
80 |
14 |
14 |
11 |
12 |
16 |
20 |
12 |
13 |
14,00 |
2,88 |
3,55 |
0,01 |
TSC3 |
344 |
4 |
5 |
1 |
3 |
4 |
2 |
4 |
1 |
3,00 |
1,51 |
0,18 |
> |
TSC2 |
68,6 |
4 |
5 |
7 |
6 |
1 |
4 |
1 |
3 |
3,88 |
2,17 |
0,48 |
> |
TSC1 |
13,8 |
6 |
5 |
2 |
4 |
3 |
3 |
1 |
2 |
3,25 |
1,67 |
0,29 |
> |
Number of mitoses (MI) +S9 mix With metabolic activation
|
|
2nd test replicate |
3rd test replicate (repeated) |
|
|
|
||||||
|
|
Parallel 1 |
Parallel 2 |
Parallel 1 |
Parallel 2 |
|
|
|
||||
|
|
M |
W |
M |
W |
M |
W |
M |
W |
|
|
|
Subst. |
Conc. (µg/mL) |
Slide 1 |
S.2 |
S.3 |
S.4 |
S.5 |
S.6 |
S.7 |
S.8 |
Average |
S.D. |
MI(%) |
NC |
- |
34 |
22 |
18 |
20 |
20 |
17 |
30 |
11 |
21,50 |
7,33 |
2,2 |
PC |
80 |
19 |
17 |
14 |
16 |
19 |
18 |
12 |
11 |
15,75 |
3,11 |
1,6 |
TSC3 |
344 |
20 |
13 |
15 |
13 |
18 |
15 |
16 |
18 |
16,00 |
2,51 |
1,6 |
TSC2 |
68,6 |
27 |
14 |
17 |
22 |
17 |
10 |
10 |
28 |
18,13 |
7,00 |
1,8 |
TSC1 |
13,8 |
16 |
17 |
11 |
20 |
13 |
15 |
20 |
14 |
15,75 |
3,20 |
1,6 |
Explanatory notes:
NC -Negative control PC -positive control
MI - mitotic index (number of mitoses) in % * - statistical significant result
** - high statistical significant result *** - very high statistical significant result
S.D. Standard deviation N - statistical not significant result
t - value - calculated t - value from the Student’s test
p - value p-value can be found using a table of values from Student's t-distribution
SSR Statistical significance of result TSC Test substance concentration
M - Man
W - Woman
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation
The test substance sulphamidic acid analyzed in terms of micronucleus test in vitro did not show mutagenic effects on the target test system.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.